What Unique Biotech does

Unique Biotech Limited is a Hyderabad, India-based privately held probiotic manufacturer founded in 2001 with 501-1000 employees. The company operates across four end-markets — human health (dietary supplements, gummies, oral rehydration solutions), animal health (pets, aquaculture, poultry, cattle), food & beverage fortification, and agriculture (biopesticides and biofertilizers) — supplying multinational nutraceutical companies, food and beverage manufacturers, animal feed companies, and research institutes globally. Its core technology platform is built on proprietary spore-forming probiotic strains — notably Bacillus coagulans Unique IS-2®, Bacillus clausii UBBC-07®, Saccharomyces boulardii Unique-28, and Lactobacillus salivarius UBLS-22 — combined with LAB Synbiotics technology, all backed by more than 50 published research papers and 20+ clinical studies per strain. The company manufactures strains and finished formulations in dosage forms including capsules, sachets, suspensions, gummies, powders, and premixes, with guaranteed stability and viability through end of shelf life as a key differentiator.

Name

Unique Biotech

Legal name

Unique Biotech Limited

Website

https://uniquebiotech.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Unique Biotech Limited is an Indian probiotic manufacturer supplying proprietary spore-forming strains and finished formulations across human health, animal health, food & beverage, and agriculture segments to global nutraceutical, dairy, and animal feed customers.

Ownership category

akta.pro rank

Product category

Probiotic Manufacturing

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412), Food Manufacturing (311), Dairy Product Manufacturing (3115)

SIC

Food And Kindred Products (2000), Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834), Agricultural Prod-Livestock & Animal Specialties (200)

akta.pro primary industry

Probiotics (Strains, Spore-Formers, Synbiotic Components) (AFAJAKAE)

akta.pro secondary industries

Probiotics (Human & Animal Strains, Spore-Formers, Synbiotic Bases) (AFAJAJAE), Probiotics & Digestive Health Supplements (CRADAGAF), Probiotic/Prebiotic Functional Beverage Production (Non-Fermented) (AFAFAFAE), Probiotic/Fermented Functional Cultured Dairy (Added Cultures/Prebiotics) Manufacturing (AFAHADAJ)

Keywords

• Probiotic manufacturing
• Nutraceutical formulations
• Contract manufacturing
• Animal probiotics
• Agricultural bioproducts

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D

Revenue model

1. Probiotic Strain Manufacturing & Sales: Manufacturing and selling proprietary probiotic strains including Bacillus coagulans Unique IS-2, Bacillus clausii UBBC-07, Saccharomyces boulardii Unique-28, and Lactobacillus salivarius UBLS-22 to nutraceutical, pharmaceutical, food and beverage companies.
2. Contract Manufacturing & Private Label: Offering contract manufacturing services and private label probiotic products for brand owners, marketers, retailers, and distributors in the health supplement industry.
3. Animal Probiotic Products: Manufacturing patented probiotic products for animals including pets, aqua, poultry, and cattle segments.
4. Agricultural Probiotics (Bio-B5): Sales of Bacillus subtilis B5-based biopesticide-cum-biofertilizer product for agricultural applications.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Unique Biotech manufactures and supplies proprietary probiotic strains (notably Bacillus coagulans Unique IS-2, Bacillus clausii UBBC-07, Saccharomyces boulardii Unique-28, and Lactobacillus salivarius UBLS-22) along with finished probiotic formulations in multiple dosage forms including capsules, gummies, sachets, suspensions, powders, and premixes. The company also offers end-to-end contract manufacturing, custom pre/probiotic blends, private label, and analytical support services to nutraceutical, pharmaceutical, food & beverage, animal health, and agricultural clients worldwide.

Product overview

Unique Biotech is an end-to-end probiotic solutions provider offering a diversified portfolio of clinically proven probiotic strains and finished formulations. The company operates as both a strain manufacturer and contract manufacturer, providing products across multiple segments: human health (dietary supplements, gummies, and oral rehydration products), animal health (pets, aquaculture, poultry, and cattle), and agriculture (bio-pesticides and bio-fertilizers). Core proprietary strains include Bacillus coagulans Unique IS-2®, Bacillus clausii UBBC-07®, Saccharomyces boulardii Unique 28, and Lactobacillus salivarius UBLS-22. The portfolio spans specific condition-targeting products such as MUSPRO and UBLAC-M for bone health, MORNING BREEZE for hangover relief, Catapro for weight management, and Lipcolac for cardiovascular health. The company supports customers through contract manufacturing, custom probiotic blending, private label, and analytical services, offering formulations in capsules, suspensions, sachets, gummies, powders, and premixes.

Differentiator

Problem solved

Functional benefit

Products and services

• Bacillus coagulans Unique IS-2® Flagship spore-forming probiotic strain with registered trademark, used in human health, food fortification, and beverages; known for heat stability and shelf-life viability.

Quantifiable outcome

• Bacillus subtilis B5 controls soil/tuber borne diseases up to 80%
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Chr. Hansen (now Novonesis): Global market leader in probiotic cultures and dairy cultures, now operating as Novonesis after merger with Novozymes. Directly comparable end-to-end probiotic strain and formulation manufacturer serving human nutrition, animal health, and plant health at a much larger scale than Unique Biotech.
• International Flavors & Fragratures (IFF) — Health & Biosciences / Danisco: Through its Danisco heritage, IFF produces HOWARU probiotic strains and supplies probiotic cultures, blends, and finished formulations to nutraceutical, F&B, and animal nutrition customers — overlapping directly with Unique Biotech's strain library and contract manufacturing offering.
• ADM (Biopolis / Protexin): Global nutrition and ingredient major with probiotics exposure via Biopolis (human probiotics) and Protexin (animal probiotics, including the Bio-Kult brand). Comparable human + animal probiotic franchise with deeper capital and global distribution.

Direct peers

• Lallemand Health Solutions: Canadian-headquartered probiotic manufacturer (Lactobacillus, Bifidobacterium, Saccharomyces strains) supplying dietary supplement, food, and pharma brands with documented clinical strains — closest direct competitor in B2B probiotic strain licensing and CDMO services.
• Lesaffre (Gnosis by Lesaffre): French yeast specialist with a dedicated Gnosis probiotic business producing spore-forming and traditional probiotic ingredients. Comparable B2B model supplying nutraceutical and F&B customers with clinically documented strains.
• BioGaia: Swedish probiotics company commercialising Lactobacillus reuteri strains with strong clinical substantiation across pediatric, oral, and gut health — highly comparable as a clinically-led probiotic licensing and branded product business.
• Probi AB: Swedish probiotic R&D and B2B licensing company supplying clinically documented Lactobacillus and Bifidobacterium strains to dietary supplement and food customers. Closely comparable to Unique Biotech's strain-licensing-plus-formulations model.
• Winclove Probiotics: Amsterdam-based probiotic B2B specialist offering proprietary multi-strain formulations (Ecologic formulations) for gut, immune, women's, and mental health indications — comparable in clinical positioning and B2B model.

Regional players

• Probiotics India Limited (Bioprex): Domestic Indian probiotic manufacturer producing spore-based and Lactobacillus strains for human pharma, nutraceutical, and animal feed markets. Most directly comparable Indian B2B competitor headquartered in India.
• GNH India (Danstar / Lallemand import): Indian distribution and formulation player in microbial cultures, yeast, and probiotics serving the local F&B and nutraceutical industry — comparable Indian-market presence and customer overlap but more distribution-led than strain-development-led.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/uniqueprobiotic
• Facebookfacebook.com/uniquebiotech
• Instagraminstagram.com/uniquebiotechlimited
• LinkedInlinkedin.com/company/unique-biotech

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Unique Biotech